PVLA
#1930
Palvella Therapeutics, Inc. - Common Stock
149.6 8 USD
+0.02%
Sector: Atención Sanitaria
Básica: USD
Divisa de beneficio: USD
Rango diario
Rango anual
Cambio diario
+2.50%
Variación mensual
+27.93%
Variación en los últimos 6 meses
+43.73%
Cambio anual
+102.68%
Cierres anteriores
146.0 3
Open
149.6 8
Mínimo
149.6 8
High
149.6 8
Volumen
32
Financials
- Market Capitalization 2.15 B
- Employee 29
- Founded N/A
- CEO N/A
- Website www.palvellatx.com
- Headquarter Nevada, United States
- FIGI BBG0055C3N57
- Industry Fabricantes de medicamentos — general
Ingresos totales
Beneficio neto
Beneficio básico por acción
Deuda total
Flujo de caja libre
Efectivo y equivalentes
Ratio precio/beneficio
-29.89
Relación precio/flujo de caja
503.83
Related tickers
| # | Nombre | Precio | 24h % | 7d % | 1M % | 1A % | Capitalización | Últimos 7 días | |
|---|---|---|---|---|---|---|---|---|---|
| 1589 |  OGN Organon & Co. Common Stock | 13.50 USD | -0.07% | -0.07% | +0.37% | +85.95% | 3.55 B USD | ||
| 1797 |  MBX MBX Biosciences, Inc. - Common Stock | 56.59 USD | -5.75% | -9.22% | +43.81% | +304.21% | 2.69 B USD | ||
| 1990 |  RAPP Rapport Therapeutics, Inc. - Common Stock | 41.46 USD | +2.14% | +4.35% | +7.86% | +58.30% | 1.98 B USD | ||
| 2056 |  GENB Generate Biomedicines, Inc. - Common Stock | 14.21 USD | -0.49% | -9.66% | +5.57% | -5.27% | 1.82 B USD |